HYPOPLASTIC MDS

Clinical trials for HYPOPLASTIC MDS explained in plain language.

Never miss a new study

Get alerted when new HYPOPLASTIC MDS trials appear

Sign up with your email to follow new studies for HYPOPLASTIC MDS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for bone marrow failure: drug calms immune attack

Disease control Recruiting now

This study tests a pill called ruxolitinib for adults whose immune system attacks their bone marrow, causing conditions like severe anemia. The drug aims to calm the immune attack and improve blood cell counts. Participants take the pill twice daily for up to 6 months and are mon…

Matched conditions: HYPOPLASTIC MDS

Phase: PHASE1, PHASE2 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control

Last updated May 22, 2026 13:53 UTC

HYPOPLASTIC MDS

Get alerted when new HYPOPLASTIC MDS trials appear

New hope for bone marrow failure: drug calms immune attack